Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Cellular & Molecular Biology Letters

Fig. 1

From: The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon

Fig. 1

The histone demethylase KDM5C interacts with CRBN. A The CRBN-interacting proteins were labeled with biotin, purified with NeutrAvidin, digested with trypsin, and analyzed by LC‒MS/MS. B Information for MS-identified tryptic peptides from KDM5C. C HA-CRBN interacted with FLAG-KDM5C. HEK293T cells were transfected with the indicated plasmids for 48 h, collected, lysed, and subjected to immunoprecipitation assay and western blotting. D Exogenous CRBN interacted with endogenous KDM5C. The plasmids of pcDNA3.1 or FLAG-CRBN were transfected into HEK293T cells for 48 h. The cells were collected, lysed, and subjected to immunoprecipitation and western blotting. E, F Endogenous KDM5C interacted with endogenous CRBN in AML cells. NB4 (E) or THP-1 (F) cells were collected, lysed, and subjected to immunoprecipitation and western blotting using the indicated antibodies

Back to article page